Trichostatin A (TSA)
(Synonyms: 曲古抑菌素A; TSA) 目录号 : GC15526
Trichostatin A (TSA) 是一种有效的组蛋白脱乙酰酶 (HDAC) 抑制剂和抗真菌抗生素,对 HDAC 的 IC50 值为 1.8 nM,具有抑制细胞生长和诱导细胞分化。
Cas No.:58880-19-6
Sample solution is provided at 25 µL, 10mM.
Trichostatin A (TSA) is A potent histone deacetylase (HDAC) inhibitor and an antifungal antibiotic with an IC50 value of 1.8 nM for HDAC[1], which has the properties of inhibiting cell growth and inducing cell differentiation.
Trichostatin A (TSA) can arrest cells in G1 and G2 phases, induce cell differentiation, and restore transformed morphology of cultured cells. Trichostatin A (TSA) inhibits proliferation of breast cancer cells in human breast cancer cell linesand resulted in hyperacetylation of histone H4[1]. Trichostatin A (TSA) promotes apoptosis and radiation-induced DNA damage in mitotic G2 gap 2 (G2/M) -arrested cells. Trichostatin A (TSA) may directly participate in DNA damage in esophageal cancer cells by reducing the acetylation of growth-associated genomic protein H3[2].Pre-treatment of RLE-6TN cells with Trichostatin A (TSA) inhibited radiation-induced EMT-like morphological alterations including elevated protein level of α-SMA and Snail, reduction of E-cadherin expression, enhanced phosphorylation of GSK3β and ERK1/2, increased generation of ROS[3].The invasive and migratory abilities of MCF-7 cells were suppressed significantly upon treatment with Trichostatin A (TSA). Treatment with Trichostatin A (TSA) led to an increased expression level of E-cadherin, and decreased expression of vimentin and, in MCF-7 cells[4]. Trichostatin A (TSA) enhanced the radiosensitivity of colon cancer cells, apoptotic cell death induced by radiation was enhanced by Trichostatin A (TSA) treatment. Trichostatin A (TSA) also induced autophagic response in colon cancer cells, while autophagy inhibition led to cell apoptosis and enhanced the radiosensitivity of colon cancer cells[5].
Trichostatin A (TSA) had pronounced antitumor activity in vivo when administered to 16 animals at a dose of 500 microg/kg by injection daily for 4 weeks compared with 14 control animals. Furthermore, Trichostatin A (TSA) did not cause any measurable toxicity in doses of up to 5 mg/kg by injection. Trichostatin A (TSA) has significant antitumor activity in vivo The antitumor activity of Trichostatin A (TSA) is attributed to differentiation induction[1].In porcine SCNT embryos,Chaetocin, Trichostatin A (TSA), and the combination significantly increased the cleavage and blastocyst formation rate, hatching/hatched blastocyst rate, and cell numbers and survival rate. The combined treatment improved the rate of development to blastocysts more so than chaetocin or Trichostatin A (TSA) alone[6].This decreased emotionality observed in stress-maladaptive mice was significantly recovered by chronic treatment with Trichostatin A (TSA) 2 h before daily exposure to restraint stress, which confirmed the development of stress adaptation. HDAC inhibitor Trichostatin A (TSA) may have a beneficial effect on stress adaptation by affecting 5-HT neural function in the brain and alleviate the emotional abnormality under conditions of excessive stress[7].
References:
[1]: Vigushin DM, Ali S, et,al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res. 2001 Apr;7(4):971-6. PMID: 11309348.
[2]: Wang S, Song M, et,al. Trichostatin A enhances radiosensitivity and radiation-induced DNA damage of esophageal cancer cells. J Gastrointest Oncol. 2021 Oct;12(5):1985-1995. doi: 10.21037/jgo-21-560. PMID: 34790366; PMCID: PMC8576220.
[3]: Nagarajan D, Wang L, et,al. Trichostatin A inhibits radiation-induced epithelial-to-mesenchymal transition in the alveolar epithelial cells. Oncotarget. 2017 Oct 9;8(60):101745-101759. doi: 10.18632/oncotarget.21664. PMID: 29254201; PMCID: PMC5731911.
[4]: Wang X, Chen S, et,al. Trichostatin A reverses epithelial-mesenchymal transition and attenuates invasion and migration in MCF-7 breast cancer cells. Exp Ther Med. 2020 Mar;19(3):1687-1694. doi: 10.3892/etm.2020.8422. Epub 2020 Jan 3. PMID: 32104221; PMCID: PMC7027139.
[5]: He G, Wang Y, et,al. Inhibition of autophagy induced by TSA sensitizes colon cancer cell to radiation. Tumour Biol. 2014 Feb;35(2):1003-11. doi: 10.1007/s13277-013-1134-z. PMID: 24122231.
[6]: Jeong PS, Yang HJ, et,al. Combined Chaetocin/Trichostatin A Treatment Improves the Epigenetic Modification and Developmental Competence of Porcine Somatic Cell Nuclear Transfer Embryos. Front Cell Dev Biol. 2021 Oct 6;9:709574. doi: 10.3389/fcell.2021.709574. PMID: 34692674; PMCID: PMC8526721.
[7]: Kimijima H, Miyagawa K, et,al. Trichostatin A, a histone deacetylase inhibitor, alleviates the emotional abnormality induced by maladaptation to stress in mice. Neurosci Lett. 2022 Jan 1;766:136340. doi: 10.1016/j.neulet.2021.136340. Epub 2021 Nov 10. PMID: 34774702.
Trichostatin A (TSA) 是一种有效的组蛋白脱乙酰酶 (HDAC) 抑制剂和抗真菌抗生素,对 HDAC[1] 的 IC50 值为 1.8 nM,具有抑制细胞生长和诱导细胞分化。
曲古抑菌素 A (TSA) 可以将细胞阻滞在 G1 和 G2 期,诱导细胞分化,并恢复培养细胞的转化形态。曲古抑菌素 A (TSA) 抑制人乳腺癌细胞系中乳腺癌细胞的增殖,并导致组蛋白 H4 过度乙酰化[1]。曲古抑菌素 A (TSA) 促进有丝分裂 G2 间隙 2 (G2/M) 阻滞细胞的细胞凋亡和辐射诱导的 DNA 损伤。曲古抑菌素A(TSA)可能通过降低生长相关基因组蛋白H3[2]的乙酰化水平直接参与食管癌细胞DNA损伤。曲古抑菌素A(TSA)预处理RLE-6TN细胞) 抑制辐射诱导的 EMT 样形态学改变,包括 α-SMA 和 Snail 蛋白水平升高、E-钙粘蛋白表达降低、GSK3β 和 ERK1/2 磷酸化增强、ROS 生成增加[3].MCF-7 细胞的侵袭和迁移能力在用曲古抑菌素 A (TSA) 处理后被显着抑制。在 MCF-7 细胞中用曲古抑菌素 A (TSA) 处理会导致 E-cadherin 表达水平升高,波形蛋白和 vimentin 表达降低[4]。曲古抑菌素A (TSA) 增强了结肠癌细胞的放射敏感性,曲古抑菌素A (TSA) 处理增强了辐射诱导的凋亡细胞死亡。曲古抑菌素A(TSA)也诱导结肠癌细胞自噬反应,抑制自噬导致细胞凋亡,增强结肠癌细胞的放射敏感性[5]。
与 14 只对照动物相比,通过每天注射 500 微克/公斤的剂量给 16 只动物给药 4 周,曲古抑菌素 A (TSA) 在体内具有显着的抗肿瘤活性。此外,曲古抑菌素 A (TSA) 在高达 5 mg/kg 的注射剂量下未引起任何可测量的毒性。 Trichostatin A (TSA) 在体内具有显着的抗肿瘤活性 Trichostatin A (TSA) 的抗肿瘤活性归因于分化诱导[1]。在猪SCNT 胚胎中,Chaetocin、Trichostatin A (TSA) 和该组合显着提高了卵裂和囊胚形成率、孵化/孵化囊胚率以及细胞数量和存活率。与单独使用毛壳菌素或曲古抑菌素 A (TSA) 相比,联合治疗更能提高胚泡的发育速度[6]。在应激适应不良小鼠中观察到的这种情绪下降通过曲古抑菌素 A 的长期治疗显着恢复(TSA) 每天暴露于束缚压力前 2 小时,这证实了压力适应的发展。 HDAC 抑制剂曲古抑菌素 A (TSA) 可能通过影响大脑中的 5-HT 神经功能对应激适应产生有益作用,并减轻过度应激条件下的情绪异常[7]。
Cell experiment [1]: | |
Cell lines |
Human breast cancer cell line |
Preparation Method |
Trichostatin A (TSA) was added to the cell culture medium. |
Reaction Conditions |
10 µM of Trichostatin A (TSA) for 96 h |
Applications |
Trichostatin A (TSA) inhibited the proliferation of 8 breast cancer cell lines, with an average IC50 value of 124.4±120.4 nM. Trichostatin A (TSA) treatment resulted in significant hyperacetylation of histone H4. |
Animal experiment [2]: | |
Animal models |
Nmu-induced tumor xenografts of virgin female inbred (Ludwig/Wistar/Olac) rats |
Preparation Method |
Sixteen animals were injected Trichostatin A (TSA) at a daily dose of 500 microg/kg for 4 weeks |
Dosage form |
500 µg/kg/day Trichostatin A (TSA), 4 weeks; injected |
Applications |
Trichostatin A (TSA) had pronounced antitumor activity in vivo when administered to 16 animals at a dose of 500 microg/kg by injection daily for 4 weeks compared with 14 control animals. Furthermore, Trichostatin A (TSA) did not cause any measurable toxicity in doses of up to 5 mg/kg by injection. TSA has significant antitumor activity in vivo The antitumor activity of TSA is attributed to differentiation induction |
References: [1]: Vigushin DM, Ali S, et,al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res. 2001 Apr;7(4):971-6. PMID: 11309348. |
Cas No. | 58880-19-6 | SDF | |
别名 | 曲古抑菌素A; TSA | ||
化学名 | (2E,4E,6R)-7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide | ||
Canonical SMILES | CC(C=C(C)C=CC(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C | ||
分子式 | C17H22N2O3 | 分子量 | 302.37 |
溶解度 | ≥ 15.12mg/mL in DMSO, ≥ 16.56 mg/mL in EtOH with ultrasonic | 储存条件 | Desiccate at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 3.3072 mL | 16.536 mL | 33.0721 mL |
5 mM | 0.6614 mL | 3.3072 mL | 6.6144 mL |
10 mM | 0.3307 mL | 1.6536 mL | 3.3072 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
-
Related Biological Data
ATL targets GAPDH to inhibit the inflammatory process.(H) Immunoprecipitated GAPDH from the control, LPS-treated (100 ng/ml), and LPS (100 ng/ml) + ATL (20 μM)-treated RAW264.7 cells and samples probed with an anti-mal-K antibody (lower panel).
The cell protein lysates were collected, 3 μM trichostatin A(GLPBIO, Montclair, United States) and 50mM nicotinamide were added for protein extraction.
Frontiers in pharmacology 12 (2021): 665376. PMID: PMID: 34335244 IF: 5.81 -
Related Biological Data
Effects of PGPSt on histone acetylation and its enzymes in 3D4/21 cells infected with PCV2 (A) Western blot detection of AcH3 and AcH4 protein expression.
the treatment groups in 6-well plates were divided into control group, TSA group(100 ng/mL), DMSO group (0.01%), PCV2 group and PGPSt treatment Groups (PCV2 + 50 μg/mL, PCV2 + 100 μg/mL, and PCV2 + 200 μg/mL PGPSt)
Microbial Pathogenesis (2024): 106592. PMID: 38423406 IF: 3.8001